Revenue $40.87B, up 26.2% on a year earlier. Premiums and services revenues $40.87B, up 27.2%. Diluted EPS $5.73 against $4.51.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.39B | +26.2% |
| Operating income | $1.36B | $1.75B | $1.10B | +23.9% |
| Net income | $693.00M | $1.18B | $543.00M | +27.6% |
| Diluted EPS | $5.73 | $9.83 | $4.51 | |
| Operating cash flow | $1.97B | $1.25B | $1.27B | +54.7% |
| Capital expenditures | -$132.00M | -$121.00M | -$114.00M | |
| Free cash flow | $1.83B | $1.13B | $1.16B | +58.5% |
| Dividend per share | $0.89 | $0.89 | $0.89 |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Premiums and services revenues | $40.87B | $32.12B | +27.2% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Humana (HUM) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/HUM/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
